Galderma, CH1335392721

Galderma stock: Quote 2.15% below latest AGM report

Published on 11/10/2026 at 17:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Galderma stock remains focused on an approved dividend and board changes. The April meeting also cleared Galderma's 2025 reporting package.

AGM decisions and current investor focus

  • Shareholders approved a gross dividend of CHF 0.35 per dividend-bearing share.
  • Harry Kirsch joined the board, while two L'Oreal representatives were elected as non-independent directors.
  • Galderma's 2025 financial, non-financial and compensation reports also received approval.
Galderma, CH1335392721, Illustration mit AI erstellt.

Galderma stock was quoted at 204.50 euros on Lang & Schwarz at 17:38 CET on Tuesday, November 10, 2026, 2.15 percent below the 209.00-euro quote cited in the latest report on Monday, November 9. The change gives investors a fresh market reference while the company’s April shareholder decisions remain the central corporate backdrop.

AGM approved payout and board changes

At the Annual General Meeting in Zug on April 22, 2026, shareholders approved all proposals put forward by the Board of Directors, according to Galderma.

The resolutions included a gross dividend of CHF 0.35 per dividend-bearing share. The distribution is to come from reserves from capital contributions under the conditions described by the company.

Board composition adds new representation

Harry Kirsch was elected as an independent board member. Samuel du Retail and Delphine Viguier-Hovasse, representatives of L'Oreal, joined as non-independent members.

Thomas Ebeling, Daniel Browne, Maria Teresa Hilado, Karen Lee Ling, Roberto Marques, Sherilyn McCoy and Flemming Ornskov were re-elected. The result preserved broad continuity while adding an independent member and two L'Oreal-linked directors.

Reporting approvals support continuity

Shareholders also approved Galderma's 2025 Annual Financial Statements, Non-Financial Report and Compensation Report. The company said detailed voting results and the official minutes would be published on its investor-relations website within two weeks of the meeting.

Galderma Group AG

  • Company: Galderma Group AG
  • ISIN: CH1335392721
  • Ticker: GALD
  • Home exchange: SIX Swiss Exchange
  • Lang & Schwarz quote: 204.50 euros at 17:38 CET on Tuesday, November 10, 2026
  • Change since the November 9 report: 2.15 percent lower than 209.00 euros

The Swiss SMI provides the broader home-market context for Galderma stock.

More news and analyses on Galderma stock

Disclaimer...
en | CH1335392721 | GALDERMA | boerse | 70487589 | bgmi